B. Müllhaupt

Discipline

Economies et finances (3) Sociologie (1) Psychologie (1)

Type de document

Articles (19) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Treatment (15) Liver (14) infection (12) Infection (12) Hepatitis C virus (11) Patients (11) Patients (11) Human beings (10) Hepatitis C (10) maladie (9) maladie (9) thérapie (8) Therapeutics (8) taux (7) Swiss (7) Fibrosis (7) Fibrosis (7) cohorte (7) adulte (6) Use (6) adulte (6) risque (5) association (5) âge (5) Ci (Chinese poetry) (5) Social groups (5) Risk (5) Persons (5) Management (5) Liver--Cancer (5)

Documents écrit par B. Müllhaupt (19) | parle de B. Müllhaupt (0)

The current and future burden of hepatitis B in Switzerland: a modelling study.
F. Negro et al. (5 juin 2023)
Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.
S. Kasmi et al. (28 févr. 2022)
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue.
J. Vieira Barbosa et al. (26 avr. 2021)
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS).
M. Roelens et al.
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study.
M. Brezzi et al. (2019)
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing.
F. About et al. (2019)
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis.
S. Beckebaum et al. (13 nov. 2018)
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.
P. Bruggmann et al. (2017)
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations.
B. Bertisch et al. (2016)
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
D.L. Braun et al. (2015)
Clinical significance of the CCR5delta32 allele in hepatitis C.
I. Morard et al. (2014)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
E. Terczyńska-Dyla et al. (2014)
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.
S. Bibert et al. (2013)
Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development.
C.M. Lange et al. (2013)
Hepatologie: Wichtiges zu chronischen Hepatitis C
B. Müllhaupt et al. (2013)
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
E. Patin et al.
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study.
J.J. Gonvers et al. (2010)
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland.
K. Overbeck et al. (2010)
HIV and solid organ transplantation: the Swiss experience.
N.J. Müller et al. (18 mars 2006)